Ecolab Inc.
Ecolab Reports Strong Q1 2024 Earnings and Announces Sale of Global Surgical Solutions Business
Summary
Ecolab Inc. announced very strong first-quarter results for 2024 with reported diluted EPS of $1.43, up 74% year-over-year, and adjusted diluted EPS of $1.34, up 52%. The company reported sales of $3.8 billion, a 5% increase from the prior year, and raised its full-year 2024 adjusted diluted EPS outlook to $6.40 - $6.70. Additionally, Ecolab has entered into a definitive agreement to sell its global surgical solutions business to Medline for $950 million in cash, with the transaction expected to close in the second half of 2024.
Profitelligence Alerts
Get alerts for ECL
Be first to know when Ecolab Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Ecolab Inc.
Ecolab Inc. is a global leader in water, hygiene, and energy technologies and services. The company provides comprehensive solutions and on-site services to promote safe food, maintain clean environments, optimize water and energy use, and improve operational efficiencies for customers worldwide. Operating across various sectors such as food service, hospitality, healthcare, and industrial markets, Ecolab addresses critical challenges related to public health, resource management, and sustainability. Founded in 1923 and headquartered in St. Paul, Minnesota, Ecolab has grown to serve over three million customer locations in more than 170 countries. By focusing on innovative technologies and personalized services, Ecolab plays a crucial role in enhancing the operational performance and environmental compliance of its clients, ultimately driving industry standards in safety and sustainability.
Official SEC Documents
Advertisement